Page 5 - Denisel Cote News Today

A Manhattan federal judge on Friday sentenced Florida private equity manager Elliot Smerling to eight years in prison for defrauding two banks of over $140 million in order to bankroll a lavish lifestyle, faulting him for a "brazen" eight-year fraud.

A New York federal judge on Wednesday threw out a proposed class action over Pfizer's Chantix recall, ruling that the consumers haven't adequately alleged that Pfizer made any misrepresentations as to the presence of a possible carcinogen in the drug.

US competition updates from the FTC regarding maximum penalty for violations, a limitation on future mergers and antitrust claims for the drug Daraprim, US competition litigation updates, and Mexico’s antitrust authority suspended several procedural deadlines

US competition updates from the FTC regarding maximum penalty for violations, a limitation on future mergers and antitrust claims for the drug Daraprim, US competition litigation updates, and Mexico’s antitrust authority suspended several procedural deadlines

Martin Shkreli cannot hide beyond First Amendment assertions against a lifetime ban from the pharmaceutical industry for antitrust violations, the Federal Trade Commission and state attorneys general told a New York federal judge Wednesday, because the whole point is to prevent future illegal conduct.

A New York federal judge on Thursday authorized a receiver to sell a Picasso etching seized from imprisoned "pharma bro" Martin Shkreli to settle a $2.6 million debt the former drug firm executive owes to a Pennsylvania pharmaceutical industry consultant.

A New York federal judge on Friday banned Martin Shkreli from participating in the pharmaceutical industry for life and fined him $64.6 million for increasing the price of a life-saving drug by 4,000% while blocking generic rivals.

Former Vyera Pharmaceuticals CEO Eliseo Salinas told a Manhattan federal judge Tuesday that he thinks Martin Shkreli's 2015 move to dramatically jack up the price of an anti-parasitic drug the company controlled was "crazy," "irresponsible" and "careless."

Former Vyera Pharmaceuticals CEO Eliseo Salinas told a Manhattan federal judge Tuesday that he thinks Martin Shkreli's 2015 move to dramatically jack up the price of an anti-parasitic drug the company controlled was "crazy," "irresponsible" and "careless."

Martin Shkreli has informed a Manhattan federal judge that he will not attend a December bench trial on the Federal Trade Commission's allegations that he and his company, Vyera Pharmaceuticals, monopolized the market for a lifesaving parasitic drug.